NPP

Bridging the Gap: How to Access Special Medical Support When Options Run Out

December 9, 2025

Navigating the Safety Net: Who Qualifies for Special Medical Support? The journey for patients living with severe, chronic, or rare diseases often involves navigating a complex web of medical, financial, and emotional challenges. While standard healthcare systems provide essential care, special support is often required for those with the highest unmet needs. This specialized support […]

Specialized Pharmaceutical Services by Trackcircle

Trackcircle specializes in providing tailored access to innovative drugs, orphan drugs, and generic drugs through a comprehensive range of programs:

Named Patient Program (NPP): Trackcircle facilitates the regular supply of new and critical medications for patients with no commercial options available in their region.

Pharmaceutical Wholesale and Supplies: Trackcircle provides tailored wholesale solutions, supplying essential medications to hospitals and clinics. We ensure swift and secure delivery of treatments, meeting the healthcare needs of institutions efficiently and reliably.

Managed Access Program: Trackcircle's program allows for the managed supply of innovative, orphan, and generic drugs, catering specifically to individual patient needs and ensuring continuous access to vital treatments.

International Pharmaceutical Export/Import: Trackcircle offers specialized services for the licensed and regulated export and import of medicines worldwide. We focus on ensuring patient safety and strict adherence to international regulatory standards, facilitating global access to essential medications.

Clinical Trials Supplies: Trackcircle provides extensive support for clinical trials, offering a reliable and efficient supply of innovative, orphan, and generic drugs to research facilities and hospitals globally.

Trackcircle's commitment extends to ensuring that these critical services are executed with the utmost professionalism and adherence to international regulatory standards, promising not just access but also the integrity and efficacy of the treatments provided.